Atlas Trials

A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism

Clinical trial NCT00290134 · COMPLETED

Trial details

NCT number
NCT00290134
Sponsor
QuatRx Pharmaceuticals Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hypogonadism
Start date
2006-02-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.